The Recall Desk
HighFDA (Devices)·Z-0588-2021·Announced 2020-12-23

BD PrecisionGlide Needles Recalled Due to Blood Contamination

Becton Dickinson is recalling BD PrecisionGlide needles because blood was found on the cannulas, posing a potential infection risk if not noticed by clinicians.

What this means for you

Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.

Our severity reasoning: The recall involves a risk-of-harm product (infection risk) where injury has not yet been reported, fitting the High severity criteria.

Plain-English summary

Becton Dickinson & Company is recalling BD PrecisionGlide Needles 30G x 1/2 (0.3 mm X 13mm), Catalog Ref No. 305106, Lot No. 9128897. The recall involves 1,430,000 units distributed worldwide, including in the United States and in Canada, China, and Singapore.

The recall was initiated because Becton Dickinson confirmed the presence of blood on the cannulas of the affected needles. The company states that a possibility of infection may exist if the blood is not noticed by the clinician prior to use.

These needles are used for general purpose injection and aspiration of fluids from vials, ampoules, and parts of the body below the surface of the skin. Clinicians and healthcare facilities should check their inventory for the specific lot number and stop using any affected units.

The recalled product

Product
BD PrecisionGlide Needle 30G x 1/2 (0.3 mm X 13mm) REF 305106 - Product Usage: used for general purpose injection and aspiration of fluids from vials, ampoules and parts of the body below the surface of the skin.
Affected units
1,430,000

Distribution

Distributed nationwide across the United States.

The notice also names 15 states specifically: